FBLG - FibroBiologics, Inc.
1.53
0.010 0.654%
Share volume: 704,339
Last Updated: 04-17-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$1.52
0.01
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-14-2024 | 08-07-2024 | 11-12-2024 | 05-14-2025 | 07-31-2025 | 10-31-2025 | 02-24-2026 | |
| Assets | ||||||||
| Total Assets | 11.399 M | 8.912 M | 10.469 M | 11.426 M | 13.907 M | 8.744 M | 9.619 M | |
| Current Assets | 8.922 M | 6.509 M | 8.198 M | 9.327 M | 10.178 M | 5.240 M | 6.349 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 18.000 K | 18.000 K | 18.000 K | 18.000 K | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 8.158 M | 5.973 M | 7.827 M | 8.667 M | 8.845 M | 4.867 M | 4.894 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 770.000 K | 799.000 K | 772.000 K | 814.000 K | 967.000 K | 908.000 K | 842.000 K | |
| Other Assets | 1.707 M | 1.604 M | 1.499 M | 1.285 M | 2.762 M | 2.596 M | 2.428 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 11.399 M | 8.912 M | 10.469 M | 11.426 M | 13.907 M | 8.744 M | 9.619 M | |
| Total liabilities | 15.262 M | 11.299 M | 7.732 M | 9.076 M | 13.047 M | 8.619 M | 3.463 M | |
| Total current liabilities | 13.985 M | 10.132 M | 6.677 M | 8.211 M | 10.964 M | 6.722 M | 1.759 M | |
| Accounts Payable | 814.000 K | 1.208 M | 1.179 M | 1.417 M | 1.801 M | 1.069 M | 945.000 K | |
| Other liabilities | 1.277 M | 1.167 M | 1.055 M | 865.000 K | 2.083 M | 1.897 M | 1.704 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 1.277 M | 1.167 M | 1.055 M | 865.000 K | 2.083 M | 1.897 M | 1.704 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -3.863 M | -2.387 M | 2.737 M | 2.350 M | 860.000 K | 125.000 K | 6.156 M | |
| Common stock | 28.954 M | 29.532 M | 35.156 M | 42.834 M | 46.002 M | 51.045 M | 60.320 M | |
| Retained earnings | -32.817 M | -31.919 M | -32.419 M | -40.484 M | -45.142 M | -50.920 M | -54.164 M |